LITESPARK-012: pembrolizumab plus lenvatinib with or without belzutifan or quavonlimab for advanced renal cell carcinoma
Article in Future Oncology (October 2023)
The most recent citing publications are shown below. View all 33 publications that cite this research output on Dimensions.
Article in Future Oncology (October 2023)
Article in Journal of Clinical Medicine (August 2023)
Article in Expert Review of Anticancer Therapy (August 2023)